← Current compounder rows

Current NDC auxiliary source row compounder:3784

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
85974-131
Product Ndc
85974-131
Product Ndc Digits
85974131
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Orlicaine Gel - Mint
Proprietary Name Suffix
[empty]
Nonproprietary Name
tetracaine hcl 4%, bupivacaine hcl 0.5%, phenylephrine 1% gel
Dosage Form Name
GEL
Route Name
TOPICAL
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Bennett Pharmaceuticals of America, LLC
Establishment Name
Bennett Pharmaceuticals of America, LLC
Establishment Fei
[empty]
Substance Name
TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
Active Ingredients Info
40 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL
History Active Ingredients Raw
TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE
History Active Ingredients Info Raw
40 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL
History Dosage Raw
GEL
Dea Schedule
[empty]
Package Ndc Raw
85974-131-52
Package Ndc
85974-131-52
Package Ndc Digits
8597413152
Package Ndc11
85974013152
Package Description
10 mL in 1 JAR (85974-131-52)
Reporting Period Raw
2025-1
Reporting Period
2025-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3784
Source Row Number
3784
Source Row Hash
cf68552e429e12ce4f2486aa28c4b756b5db9d09b95335fea6c64fc9432bf198
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "85974-131",
    "DEASCHEDULE": "",
    "LABELERNAME": "Bennett Pharmaceuticals of America, LLC",
    "SUBSTANCENAME": "TETRACAINE HYDROCHLORIDE; BUPIVACAINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "GEL",
    "NDCPACKAGECODE": "85974-131-52",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Orlicaine Gel - Mint",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "tetracaine hcl 4%, bupivacaine hcl 0.5%, phenylephrine 1% gel",
    "PACKAGEDESCRIPTION": "10 mL in 1 JAR (85974-131-52)",
    "ACTIVEINGREDIENTSINFO": "40 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3784
Source Row Number
3784
Status Scope
package
Lookup Ndc
85974-131-52
Lookup Ndc Digits
8597413152
Product Ndc
85974-131
Product Ndc Digits
85974131
Package Ndc
85974-131-52
Package Ndc Digits
8597413152
Package Ndc11
85974013152
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-1
Reporting Period
2025-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
cf68552e429e12ce4f2486aa28c4b756b5db9d09b95335fea6c64fc9432bf198
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45